Evaluation of a new measure of blood glucose variability in diabetes.

Abstract:

OBJECTIVE:Recent studies show the importance of controlling blood glucose variability in relationship to both reducing hypoglycemia and attenuating the risk for cardiovascular and behavioral complications due to hyperglycemia. It is therefore important to design variability measures that are equally predictive of low and high blood glucose excursions. RESEARCH DESIGN AND METHODS:We introduce the average daily risk range (ADRR), a variability measure computed from routine self-monitored blood glucose (SMBG) data. The ADRR was constructed using a development dataset for 39 and 31 adults with type 1 and type 2 diabetes, respectively. The formula was then fixed, and the ADRR was compared against other variability measures using an independent validation dataset containing approximately 4 months of SMBG for 254 and 81 adults with type 1 and type 2 diabetes. RESULTS:From the 1st month of validation SMBG data, we computed the ADRR, blood glucose SD and coefficient of variation, daily blood glucose range and interquartile range, mean amplitude of glycemic excursion, M-value, and lability index. Then all measures were tested as predictors of low blood glucose (<2.2 mmol/l; <3.9 mmol/l) and high (>10 mmol/l; >22.2 mmol/l) events in the subsequent 3 months. The ADRR was the best predictor of both hypoglycemia and hyperglycemia, with a 6-fold increase in the likelihood of hypoglycemia and 3.5-fold increase in the likelihood of hyperglycemia across its risk categories. CONCLUSIONS:In a large SMBG database, the ADRR showed strong association with subsequent out-of-control glucose readings. Compared with other variability measures, the ADRR demonstrated a superior balance of sensitivity to predicting both hypoglycemia and hyperglycemia. This prediction was independent from type of diabetes.

journal_name

Diabetes Care

journal_title

Diabetes care

authors

Kovatchev BP,Otto E,Cox D,Gonder-Frederick L,Clarke W

doi

10.2337/dc06-1085

subject

Has Abstract

pub_date

2006-11-01 00:00:00

pages

2433-8

issue

11

eissn

0149-5992

issn

1935-5548

pii

29/11/2433

journal_volume

29

pub_type

杂志文章
  • Release of platelet plasminogen activator inhibitor 1 in whole blood is increased in patients with type II diabetes.

    abstract:OBJECTIVE:To compare platelet plasminogen activator inhibitor 1 (PAI-1) release in type II diabetic patients and healthy control subjects. RESEARCH DESIGN AND METHODS:We studied a group of 27 diabetic patients and a group of 16 nondiabetic control subjects. Whole-blood platelet aggregation, defined as a decrease in pl...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/diacare.18.8.1150

    authors: Jokl R,Klein RL,Lopes-Virella MF,Colwell JA

    更新日期:1995-08-01 00:00:00

  • Hyperinsulinism complicating control of diabetes mellitus by an artificial beta-cell.

    abstract::Serum free insulin concentrations were measured in diabetic subjects given insulin intravenously by a glucose-controlled insulin infusion system ("closed-loop" artificial beta-cell) in two experimental situations: hourly during the day while given their usual diet and at short intervals after administration of a stand...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/diacare.3.2.274

    authors: Horwitz DL,Zeidler A,Gonen B,Jaspan JB

    更新日期:1980-03-01 00:00:00

  • Impaired awareness of hypoglycemia in a population-based sample of children and adolescents with type 1 diabetes.

    abstract:OBJECTIVE:To determine the prevalence and clinical associations of impaired awareness of hypoglycemia in a population-based sample of children and adolescents with type 1 diabetes. RESEARCH DESIGN AND METHODS:A validated questionnaire was administered to 656 patients with type 1 diabetes over a 6-month period to deter...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/dc09-0541

    authors: Ly TT,Gallego PH,Davis EA,Jones TW

    更新日期:2009-10-01 00:00:00

  • Benchmarking is associated with improved quality of care in type 2 diabetes: the OPTIMISE randomized, controlled trial.

    abstract:OBJECTIVE:To assess prospectively the effect of benchmarking on quality of primary care for patients with type 2 diabetes by using three major modifiable cardiovascular risk factors as critical quality indicators. RESEARCH DESIGN AND METHODS:Primary care physicians treating patients with type 2 diabetes in six Europea...

    journal_title:Diabetes care

    pub_type: 杂志文章,随机对照试验

    doi:10.2337/dc12-1853

    authors: Hermans MP,Elisaf M,Michel G,Muls E,Nobels F,Vandenberghe H,Brotons C,OPTIMISE International Steering Committee.

    更新日期:2013-11-01 00:00:00

  • More impact of microalbuminuria on retinopathy than moderately reduced GFR among type 2 diabetic patients.

    abstract:OBJECTIVE:The current study aimed to investigate whether microalbuminuria or moderately decreased glomerular filtration rate (GFR) is a better predictor for the development and progression of retinopathy in type 2 diabetic patients. RESEARCH DESIGN AND METHODS:Type 2 diabetic patients without cardiovascular diseases, ...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/dc11-1955

    authors: Chen YH,Chen HS,Tarng DC

    更新日期:2012-04-01 00:00:00

  • Periodontal infection, systemic inflammation, and insulin resistance: results from the continuous National Health and Nutrition Examination Survey (NHANES) 1999-2004.

    abstract:OBJECTIVE:Adverse microbial exposures might contribute to diabetogenesis. We hypothesized that clinical periodontal disease (a manifestation of microbial exposures in dysbiotic biofilms) would be related to insulin resistance among diabetes-free participants. The roles of inflammatory mediation and effect modification ...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/dc12-0072

    authors: Demmer RT,Squillaro A,Papapanou PN,Rosenbaum M,Friedewald WT,Jacobs DR Jr,Desvarieux M

    更新日期:2012-11-01 00:00:00

  • Glycemic Outcomes of Use of CLC Versus PLGS in Type 1 Diabetes: A Randomized Controlled Trial.

    abstract:OBJECTIVE:Limited information is available about glycemic outcomes with a closed-loop control (CLC) system compared with a predictive low-glucose suspend (PLGS) system. RESEARCH DESIGN AND METHODS:After 6 months of use of a CLC system in a randomized trial, 109 participants with type 1 diabetes (age range, 14-72 years...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/dc20-0124

    authors: Brown SA,Beck RW,Raghinaru D,Buckingham BA,Laffel LM,Wadwa RP,Kudva YC,Levy CJ,Pinsker JE,Dassau E,Doyle FJ 3rd,Ambler-Osborn L,Anderson SM,Church MM,Ekhlaspour L,Forlenza GP,Levister C,Simha V,Breton MD,Kollman C,

    更新日期:2020-08-01 00:00:00

  • Medical nutrition therapy and lifestyle interventions.

    abstract::Nutrient intake plays a significant role in the health outcomes of all pregnant women. In a pregnancy complicated by gestational diabetes mellitus (GDM), excellent glucose control is as foundational as appropriate weight gain and adequate nutrient intake. The controversies in GDM management include the following: how ...

    journal_title:Diabetes care

    pub_type: 杂志文章,评审

    doi:10.2337/dc07-s214

    authors: Reader DM

    更新日期:2007-07-01 00:00:00

  • Effect of chronic intermittent intravenous insulin therapy on antihypertensive medication requirements in IDDM subjects with hypertension and nephropathy.

    abstract:OBJECTIVE:The prevalence of systemic hypertension is increased in patients with diabetes. In this prospective, randomized, crossover clinical trial, we assessed antihypertensive effects of chronic intermittent intravenous insulin therapy (CIIIT) on insulin-dependent diabetes mellitus (IDDM) subjects with hypertension a...

    journal_title:Diabetes care

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.2337/diacare.18.9.1260

    authors: Aoki TT,Grecu EO,Prendergast JJ,Arcangeli MA,Meisenheimer R

    更新日期:1995-09-01 00:00:00

  • Advancing insulin therapy in type 2 diabetes previously treated with glargine plus oral agents: prandial premixed (insulin lispro protamine suspension/lispro) versus basal/bolus (glargine/lispro) therapy.

    abstract:OBJECTIVE:The purpose of this study was to compare two analog insulin therapies (prandial premixed therapy [PPT] versus basal/bolus therapy [BBT]) in type 2 diabetic patients previously treated with insulin glargine (>or=30 units/day) plus oral agents, with the aim of demonstrating noninferiority of PPT to BBT. RESEAR...

    journal_title:Diabetes care

    pub_type: 杂志文章,随机对照试验

    doi:10.2337/dc07-1122

    authors: Rosenstock J,Ahmann AJ,Colon G,Scism-Bacon J,Jiang H,Martin S

    更新日期:2008-01-01 00:00:00

  • Cardiovascular Determinants of Aerobic Exercise Capacity in Adults With Type 2 Diabetes.

    abstract:OBJECTIVE:To assess the relationship between subclinical cardiac dysfunction and aerobic exercise capacity (peak VO2) in adults with type 2 diabetes (T2D), a group at high risk of developing heart failure. RESEARCH DESIGN AND METHODS:Cross-sectional study. We prospectively enrolled a multiethnic cohort of asymptomatic...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/dc20-0706

    authors: Gulsin GS,Henson J,Brady EM,Sargeant JA,Wilmot EG,Athithan L,Htike ZZ,Marsh AM,Biglands JD,Kellman P,Khunti K,Webb D,Davies MJ,Yates T,McCann GP

    更新日期:2020-09-01 00:00:00

  • Family functioning and metabolic control of school-aged children with IDDM.

    abstract::The relationship of two aspects of family life to metabolic control were examined as part of a longitudinal study of school-aged children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). Glycosylated hemoglobin level was the primary index of metabolic control; weight-adjusted insulin dosage served as a...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/diacare.12.6.409

    authors: Kovacs M,Kass RE,Schnell TM,Goldston D,Marsh J

    更新日期:1989-06-01 00:00:00

  • Reduced testing frequency for glycated hemoglobin, HbA1c, is associated with deteriorating diabetes control.

    abstract:OBJECTIVE:We previously showed that in patients with diabetes mellitus, glycated hemoglobin (HbA1c) monitoring outside international guidance on testing frequency is widespread. Here we examined the relationship between testing frequency and diabetes control to test the hypothesis that retest interval is linked to chan...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/dc14-0297

    authors: Driskell OJ,Holland D,Waldron JL,Ford C,Scargill JJ,Heald A,Tran M,Hanna FW,Jones PW,Pemberton RJ,Fryer AA

    更新日期:2014-10-01 00:00:00

  • Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes.

    abstract:OBJECTIVE:Advanced glycation end products (AGEs) are thought to have a role in the pathogenesis of diabetes complications. We recently reported the association between skin autofluorescence, as a measure of tissue AGE accumulation, and diabetic neuropathy in a selected diabetic population. In this study, we investigate...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/dc05-2173

    authors: Lutgers HL,Graaff R,Links TP,Ubink-Veltmaat LJ,Bilo HJ,Gans RO,Smit AJ

    更新日期:2006-12-01 00:00:00

  • Impaired glucose tolerance and diabetes mellitus in elderly subjects.

    abstract::In a 10-yr prospective population study 406 subjects who were 70 yr old received an oral glucose tolerance test. Of these subjects 169 were retested at 80. Three sets of diagnostic criteria were evaluated, of which the WHO criteria are recommended for screening studies in this age group. The prevalences of diabetes me...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/diacare.5.6.600

    authors: Agner E,Thorsteinsson B,Eriksen M

    更新日期:1982-11-01 00:00:00

  • Low bone mineral density and its predictors in type 1 diabetic patients evaluated by the classic statistics and artificial neural network analysis.

    abstract:OBJECTIVE:To investigate factors associated with bone mineral density (BMD) in type 1 diabetes by classic statistic and artificial neural networks. RESEARCH DESIGN AND METHODS:A total of 175 eugonadal type 1 diabetic patients (age 32.8 ± 8.4 years) and 151 age- and BMI-matched control subjects (age 32.6 ± 4.5 years) w...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/dc11-0764

    authors: Eller-Vainicher C,Zhukouskaya VV,Tolkachev YV,Koritko SS,Cairoli E,Grossi E,Beck-Peccoz P,Chiodini I,Shepelkevich AP

    更新日期:2011-10-01 00:00:00

  • Pharmacological treatment of the pathogenetic defects in type 2 diabetes: the randomized multicenter South Danish Diabetes Study.

    abstract:OBJECTIVE:To determine the effect of treatment with insulin aspart compared with NPH insulin, together with metformin/placebo and rosiglitazone/placebo. The hypothesis was that combined correction of major pathogenetic defects in type 2 diabetes would result in optimal glycemic control. RESEARCH DESIGN AND METHODS:Thi...

    journal_title:Diabetes care

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.2337/dc10-0531

    authors: Gram J,Henriksen JE,Grodum E,Juhl H,Hansen TB,Christiansen C,Yderstræde K,Gjessing H,Hansen HM,Vestergaard V,Hangaard J,Beck-Nielsen H

    更新日期:2011-01-01 00:00:00

  • Mediterranean Diet, Retinopathy, Nephropathy, and Microvascular Diabetes Complications: A Post Hoc Analysis of a Randomized Trial.

    abstract:OBJECTIVE:To date no clinical trials have evaluated the role of dietary patterns on the incidence of microvascular diabetes complications. We hypothesized that a nutritional intervention based on the Mediterranean diet (MedDiet) would have greater protective effect on diabetic retinopathy and nephropathy than a low-fat...

    journal_title:Diabetes care

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.2337/dc15-1117

    authors: Díaz-López A,Babio N,Martínez-González MA,Corella D,Amor AJ,Fitó M,Estruch R,Arós F,Gómez-Gracia E,Fiol M,Lapetra J,Serra-Majem L,Basora J,Basterra-Gortari FJ,Zanon-Moreno V,Muñoz MÁ,Salas-Salvadó J,PREDIMED Study Inves

    更新日期:2015-11-01 00:00:00

  • Prevalence of diabetes and ethnic differences in cardiovascular risk factors. The 1992 Singapore National Health Survey.

    abstract:OBJECTIVE:The purpose of the 1992 Singapore National Health Survey was to determine the current distribution of major noncommunicable diseases and their risk factors, including the prevalence of diabetes and dyslipidemia, in Singapore. RESEARCH DESIGN AND METHODS:A combination of disproportionate stratified sampling a...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/diacare.22.2.241

    authors: Tan CE,Emmanuel SC,Tan BY,Jacob E

    更新日期:1999-02-01 00:00:00

  • Effects of sucrose on carbohydrate and lipid metabolism in NIDDM patients.

    abstract::Recently, there has been increasing interest toward the liberalization of sucrose in the diets of individuals with non-insulin-dependent diabetes mellitus (NIDDM). However, there is evidence from several well-controlled prospective studies demonstrating that the consumption of moderate amounts of sucrose may result in...

    journal_title:Diabetes care

    pub_type: 杂志文章,评审

    doi:10.2337/diacare.12.1.62

    authors: Hollenbeck CB,Coulston AM,Reaven GM

    更新日期:1989-01-01 00:00:00

  • The efficacy and safety of imeglimin as add-on therapy in patients with type 2 diabetes inadequately controlled with sitagliptin monotherapy.

    abstract:OBJECTIVE:This 12-week study assessed the efficacy and tolerability of imeglimin as add-on therapy to the dipeptidyl peptidase-4 inhibitor sitagliptin in patients with type 2 diabetes inadequately controlled with sitagliptin monotherapy. RESEARCH DESIGN AND METHODS:In a multicenter, randomized, double-blind, placebo-c...

    journal_title:Diabetes care

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.2337/dc13-2349

    authors: Fouqueray P,Pirags V,Diamant M,Schernthaner G,Lebovitz HE,Inzucchi SE,Bailey CJ

    更新日期:2014-07-01 00:00:00

  • Collaborative care management of major depression among low-income, predominantly Hispanic subjects with diabetes: a randomized controlled trial.

    abstract:OBJECTIVE:To determine whether evidence-based socioculturally adapted collaborative depression care improves receipt of depression care and depression and diabetes outcomes in low-income Hispanic subjects. RESEARCH DESIGN AND METHODS:This was a randomized controlled trial of 387 diabetic patients (96.5% Hispanic) with...

    journal_title:Diabetes care

    pub_type: 杂志文章,随机对照试验

    doi:10.2337/dc09-1711

    authors: Ell K,Katon W,Xie B,Lee PJ,Kapetanovic S,Guterman J,Chou CP

    更新日期:2010-04-01 00:00:00

  • Racial Differences in the Performance of Existing Risk Prediction Models for Incident Type 2 Diabetes: The CARDIA Study.

    abstract:OBJECTIVE:In 2010, the American Diabetes Association (ADA) added hemoglobin A1c (A1C) to the guidelines for diagnosing type 2 diabetes. However, existing models for predicting diabetes risk were developed prior to the widespread adoption of A1C. Thus, it remains unknown how well existing diabetes risk prediction models...

    journal_title:Diabetes care

    pub_type: 杂志文章,多中心研究

    doi:10.2337/dc15-0509

    authors: Lacy ME,Wellenius GA,Carnethon MR,Loucks EB,Carson AP,Luo X,Kiefe CI,Gjelsvik A,Gunderson EP,Eaton CB,Wu WC

    更新日期:2016-02-01 00:00:00

  • Effect of socioeconomic status on mortality among people with type 2 diabetes: a study from the Scottish Diabetes Research Network Epidemiology Group.

    abstract:OBJECTIVE:The study objective was to describe the effect of socioeconomic status (SES) on mortality among people with type 2 diabetes. RESEARCH DESIGN AND METHODS:We used a population-based national electronic diabetes database for 35- to 84-year-olds in Scotland for 2001-2007 linked to mortality records. SES was deri...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/dc10-1862

    authors: Walker JJ,Livingstone SJ,Colhoun HM,Lindsay RS,McKnight JA,Morris AD,Petrie JR,Philip S,Sattar N,Wild SH,Scottish Diabetes Research Network Epidemiology Group.

    更新日期:2011-05-01 00:00:00

  • Fulminant type 1 diabetes: a nationwide survey in Japan.

    abstract:OBJECTIVE:To describe the clinical and immunologic characteristics of fulminant type 1 diabetes, a novel subtype of type 1 diabetes, we conducted a nationwide survey. RESEARCH DESIGN AND METHODS:History and laboratory data, including islet-related autoantibodies, were examined in 222 patients with fulminant and nonful...

    journal_title:Diabetes care

    pub_type: 杂志文章,多中心研究

    doi:10.2337/diacare.26.8.2345

    authors: Imagawa A,Hanafusa T,Uchigata Y,Kanatsuka A,Kawasaki E,Kobayashi T,Shimada A,Shimizu I,Toyoda T,Maruyama T,Makino H

    更新日期:2003-08-01 00:00:00

  • Reinterpreting Cardiorenal Protection of Renal Sodium-Glucose Cotransporter 2 Inhibitors via Cellular Life History Programming.

    abstract::Cardiovascular outcome trials have provided evidence that sodium-glucose cotransporter 2 inhibitor (SGLT2i) treatment is associated with remarkably favorable cardiovascular outcomes. Here, we offer a novel hypothesis that may encompass many of these hypothetical mechanisms, i.e., the ability of SGLT2i to modify the tr...

    journal_title:Diabetes care

    pub_type: 评论,杂志文章

    doi:10.2337/dc19-1410

    authors: Avogaro A,Fadini GP,Del Prato S

    更新日期:2020-03-01 00:00:00

  • Closing the gap: the problem of diabetes mellitus in the United States. The Carter Center of Emory University.

    abstract::Diabetes mellitus is a major public health problem and a leading cause of death, disability, and cost in the United States. We review the epidemiology of diabetes and its complications, the costs of diabetes, and discuss intervention strategies to reduce the burden of diabetes in the United States. ...

    journal_title:Diabetes care

    pub_type: 杂志文章,评审

    doi:10.2337/diacare.8.4.391

    authors:

    更新日期:1985-07-01 00:00:00

  • Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset. Belgian Diabetes Registry.

    abstract:OBJECTIVE:To investigate whether the presence of antibody markers at diagnosis could help predict the rapid decrease in residual beta-cell function noted in some, but not all, patients with recent-onset type 1 diabetes. RESEARCH DESIGN AND METHODS:We measured random C-peptide levels (radioimmunoassay); islet cell cyto...

    journal_title:Diabetes care

    pub_type: 杂志文章,多中心研究

    doi:10.2337/diacare.23.8.1072

    authors: Decochez K,Keymeulen B,Somers G,Dorchy H,De Leeuw IH,Mathieu C,Rottiers R,Winnock F,ver Elst K,Weets I,Kaufman L,Pipeleers DG,Gorus FK,Belgian Diabetes Registry.

    更新日期:2000-08-01 00:00:00

  • Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1.

    abstract:OBJECTIVE:There is little information regarding the pattern of metabolic deterioration before the onset of type 1 diabetes. The goal of this study was to utilize data from the Diabetes Prevention Trial-Type 1 (DPT-1) to obtain a picture of the metabolic progression to type 1 diabetes over a period of approximately 2.5 ...

    journal_title:Diabetes care

    pub_type: 杂志文章,随机对照试验

    doi:10.2337/diacare.29.03.06.dc05-1006

    authors: Sosenko JM,Palmer JP,Greenbaum CJ,Mahon J,Cowie C,Krischer JP,Chase HP,White NH,Buckingham B,Herold KC,Cuthbertson D,Skyler JS

    更新日期:2006-03-01 00:00:00

  • Immune Checkpoint Inhibitor-Associated Diabetes: A Single-Institution Experience.

    abstract:OBJECTIVE:To characterize immune checkpoint inhibitor-associated diabetes mellitus (ICI-DM) in a single-institution case series. RESEARCH DESIGN AND METHODS:Retrospective chart review of 18 patients with new-onset ICI-DM following anti-programmed cell death protein 1 (PD-1)/anti-programmed cell death protein ligand 1 ...

    journal_title:Diabetes care

    pub_type: 杂志文章

    doi:10.2337/dc20-0609

    authors: Byun DJ,Braunstein R,Flynn J,Zheng J,Lefkowitz RA,Kanbour S,Girotra M

    更新日期:2020-12-01 00:00:00